By Brendan Pierson and Dietrich Knauth
由布倫丹·皮爾森和迪特里克·克諾思
July 26 (Reuters) - A Jury on Friday Found That Abbott Laboratories' Abt.n Specialized Formula for Premature Infants Caused an Illinois Girl to Develop a Dangerous Bowel Disease, Ordering the Healthcare Company to Pay $95 Million in Compensatory Damages.
7月26日，路透社消息稱，陪審團於週五作出判決，認定雅培實驗室 (Abbott Laboratories)爲早產兒提供的特殊配方導致伊利諾伊州一名女嬰患上危險的腸疾，判決該醫療保健公司支付9500萬美元的賠償損失。Abt.n這份來自密蘇里州聖路易斯州法庭的裁決是針對雅培公司的第一次審判，數百起類似訴訟案件還在全國各地各級法院等待審判，路透社通過法庭視圖網絡查看了相關內容。陪審團現在將考慮是否對女嬰的母親給予懲罰性賠償。
The Verdict in St. Louis, Missouri State Court Comes in the First Trial Against the Company Out of Hundreds of Similar Claims Over the Formula Pending in Courts Around the Country, Which Reuters Viewed via Courtroom View Network. the Jury Will Now Consider Whether to Award the Girl's Mother Punitive Damages.
(Reporting by Brendan Pierson and Dietrich Knauth in New York, Editing by Alexia Garamfalvi and Diane Craft)
（紐約布倫丹·皮爾森和迪特里克·諾斯報道，艾莉克西婭·加蘭法爾維和黛安·克拉夫特編輯）
((Brendan.pierson@Thomsonreuters.com; 332-219-1345 (Desk); 646-306-0235 (Cell);))
((brendan.pierson@thomsonreuters.com; 332-219-1345(辦公室); 646-306-0235(手機);）